The Hormone Assay Core assists investigators in the measurement of hormones in biologic fluids as related to diabetes, endocrine and metabolic research. The core provides space, equipment, and personnel for sample analysis and method development. User charge backs support the cost of reagents, supplies and pro-rated service contracts. The analysis available include 1) insulin, 2) free insulin, 3) glucagon, 4) cortisol, 5) catecholamines, 6) growth hormone, 7) c-peptides (human, canine, porcine), 8) pancreatic polypeptides, 9) leptin, 10) ratcorticosterone, and 11) GLP-1 (active). Several of these assays are available in """"""""micro"""""""" methods for the analysis of hormone levels in very small volumes of plasma or blood. Furthermore, some assays are designed to measure hormones in a particular species. The core has the potential to develop new tests and technologies to expand the scope of its current testing. An annual survey is conducted to determine the needs of users for new assays. Over the past grant period, there has been an increased demand for at least half of the services offered and a constant demand for the remainder. The core will be expanded to meet an expected growth in demand that is anticipated as a result of funding of a Murine Metabolic and Physiology Center. An advisory Committees will deal with issues of coordination between the DRTC and MMPC, as well as user fees and new service implementation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Comprehensive Center (P60)
Project #
5P60DK020593-33
Application #
8281516
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2011-04-01
Budget End
2012-03-31
Support Year
33
Fiscal Year
2011
Total Cost
$375,704
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Bolus, W Reid; Peterson, Kristin R; Hubler, Merla J et al. (2018) Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments. Mol Metab 8:86-95
West, Kathryn L; Kelm, Nathaniel D; Carson, Robert P et al. (2018) Myelin volume fraction imaging with MRI. Neuroimage 182:511-521
Barke, Theresa L; Goldstein, Jeffery A; Sundermann, Alexandra C et al. (2018) Gestational diabetes mellitus is associated with increased CD163 expression and iron storage in the placenta. Am J Reprod Immunol 80:e13020
Rohrbough, Jeffrey; Nguyen, Hong-Ngan; Lamb, Fred S (2018) Modulation of ClC-3 gating and proton/anion exchange by internal and external protons and the anion selectivity filter. J Physiol 596:4091-4119
Schlegel, Cameron; Lapierre, Lynne A; Weis, Victoria G et al. (2018) Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase. Traffic 19:879-892
Moore, Mary Courtney; Smith, Marta S; Farmer, Ben et al. (2018) Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day. Diabetes 67:1237-1245
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255
Moore, Mary Courtney; Kelley, David E; Camacho, Raul C et al. (2018) Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts. Diabetes 67:1173-1181
Funkhouser-Jones, Lisa J; van Opstal, Edward J; Sharma, Ananya et al. (2018) The Maternal Effect Gene Wds Controls Wolbachia Titer in Nasonia. Curr Biol 28:1692-1702.e6
Hart, Nathaniel J; Aramandla, Radhika; Poffenberger, Gregory et al. (2018) Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight 3:

Showing the most recent 10 out of 1487 publications